סיפרול er 0.375
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 0.375 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול 0.75 er
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 0.75 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
סיפרול 1.5 er
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליות עם שחרור נרחב - pramipexole dihydrochloride monohydrate 1.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
אופב 100 מג
boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 100 mg
אופב 150 מג
boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 150 mg
ג'ארדיאנס דואו 12.5 מג 500 מג
boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - טבליות מצופות פילם - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin
ג'ארדיאנס דואו 5 מג 500 מג
boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - טבליות מצופות פילם - empagliflozin 5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin
פרדקסה 110
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 110 mg - dabigatran etexilate
פרדקסה 110
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 110 mg - dabigatran etexilate
פרדקסה 75
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate - dabigatran etexilate - primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.